Clover Health Investments Stock (NASDAQ: CLOV)

Clover Health Investments Stock (NASDAQ:CLOV), Trade Ideas

Clover Health Investments

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALTI

BNAI

CJET

CLOV

FOUR

GERN

HGAS

IDAI

JOAN

LIDR

LOGI

NBTX

NVEI

RILY

TSVT

VJET

Shares of  Nuvei Corp (NASDAQ: NVEI) rose sharply in today’s pre-market trading following a report indicating the company is in buyout talks with Advent International.

Nuvei shares jumped 14.1% to $24.82 in pre-market trading

Why Nuvei Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Intraday Update

ADTH

AIRE

ANNX

ATER

BGNE

BIRD

BTOG

CMTL

DLTR

ECDA

EDUC

GXAI

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

HRTX

Kintara Therapeutics, Inc. - Common Stock

KTRA

LICY

LUNA

MINM

MNMD

NAAS

NATR

NCNA

NMRA

PIII

PRTG

RXRX

SIGA

SKIN

SMMT

SURG

SWIN

VERI

Shares of  Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

LEGN

MXCT

UNFI

U.S. stock futures were mixed this morning, with the Nasdaq futures falling by around 20 points on Wednesday.

Beauty Health Posts Upbeat Sales, Joins SIGA Technologies, MaxCyte And Other Big Stocks Moving Higher In Wednesday&#39;s Pre-Market Session

Clover Health Investments, Corp. - Class A Common stock

Clover Health Investments Corp

CLOVER CORP LTD by Clover Corporation Ltd.

Clover Corp Ltd

Clover Finance - United States Dollar

Clover Leaf Capital Corp. - Class A Common Stock

Clover Leaf Capital Corp

Clover Leaf Capital Corp. - Rights

CLOVERLEAF KENNEL CLB A by Cloverleaf Kennel Club

Cloverleaf Kennel Club

Clovis Oncology Inc

<p>UBS  analyst Stephen Ju   maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Buy and lowers the price target from $610 to $575.</p>


Price Target

Analyst Ratings

UBS Maintains Buy on Meta Platforms, Lowers Price Target to $575

WIIM

FCNCA

First Citizens BancShares are trading higher after the company reported better-than-expected Q1 adjusted EPS results.

<p>UBS  analyst Stephen Ju   maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Buy and raises the price target from $198 to $215.</p>


AMZN

UBS Maintains Buy on Amazon.com, Raises Price Target to $215

<p>Cantor Fitzgerald  analyst Olivia Brayer   reiterates Biomarin Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>) with a Overweight and maintains $110 price target.</p>


Reiteration

BMRN

Cantor Fitzgerald Reiterates Overweight on Biomarin Pharmaceutical, Maintains $110 Price Target

Global

Royal Caribbean Executive Says Bookings Have Been Outpacing Last Year By A Wide Margin On A Weekly Basis Despite Having Less Inventory Remaining For Sale

<p>NorthEast Community (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NECB#NASDAQ">NECB</a>) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.72 by 19.44 percent. This is a 11.69 percent increase over earnings of $0.77 per share from the same period last year.</p>


Earnings

NECB

NorthEast Community Q1 EPS $0.86 Beats $0.72 Estimate

<p>Cantor Fitzgerald  analyst Louise Chen   reiterates Cidara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) with a Overweight.</p>


CDTX

Cantor Fitzgerald Reiterates Overweight on Cidara Therapeutics

<p>Wells Fargo  analyst Steven Cahall   maintains Interpublic Gr of Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPG#NYSE">IPG</a>) with a Equal-Weight and lowers the price target from $32 to $31.</p>


Wells Fargo Maintains Equal-Weight on Interpublic Gr of Cos, Lowers Price Target to $31

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>JPMorgan Chase</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with JPM, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 33 uncommon options trades for JPMorgan Chase.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 48% bullish and 45%, bearish.</p>
<p>Out of all of the special options we uncovered, 23 are puts, for a total amount of $1,502,520, and 10 are calls, for a total amount of $494,926.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $175.0 and $220.0 for JPMorgan Chase, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for JPMorgan Chase's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of JPMorgan Chase's whale activity within a strike price range from $175.0 to $220.0 in the last 30 days. </p>
<h3>JPMorgan Chase 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714055467_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$21.0</td>
<td>$19.9</td>
<td>$19.9</td>
<td>$195.00</td>
<td>$189.0K</td>
<td>136</td>
<td>106</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$2.68</td>
<td>$2.63</td>
<td>$2.65</td>
<td>$190.00</td>
<td>$145.7K</td>
<td>8.7K</td>
<td>349</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$11.35</td>
<td>$11.3</td>
<td>$11.3</td>
<td>$190.00</td>
<td>$136.7K</td>
<td>1.2K</td>
<td>10</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$1.82</td>
<td>$1.8</td>
<td>$1.82</td>
<td>$180.00</td>
<td>$109.3K</td>
<td>7.2K</td>
<td>1.1K</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$5.85</td>
<td>$5.75</td>
<td>$5.75</td>
<td>$190.00</td>
<td>$94.3K</td>
<td>1.3K</td>
<td>7</td>
</tr>
</tbody>
</table>
</p>
<h3>About JPMorgan Chase</h3>
<p>JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $3.9 trillion in assets. It is organized into four major segments--consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.</p>
<p>Following our analysis of the options activities associated with JPMorgan Chase, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of JPMorgan Chase</h3>
<ul>
<li>With a volume of 1,632,572, the price of JPM is down -0.85% at $191.44. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 78 days.</li>
</ul>
<h3>What Analysts Are Saying About JPMorgan Chase</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $211.4.</p>
<ul>
<li>Maintaining their stance, an analyst from Morgan Stanley continues to hold a Overweight rating for JPMorgan Chase, targeting a price of $216. </li>
<li>Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for JPMorgan Chase, targeting a price of $217. </li>
<li>An analyst from UBS has decided to maintain their Buy rating on JPMorgan Chase, which currently sits at a price target of $219. </li>
<li>An analyst from Evercore ISI Group has decided to maintain their Outperform rating on JPMorgan Chase, which currently sits at a price target of $210. </li>
<li>An analyst from BMO Capital persists with their Market Perform rating on JPMorgan Chase, maintaining a target price of $195. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for JPMorgan Chase with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

Unpacking the Latest Options Trading Trends in JPMorgan Chase

Macro Economic Events

Econ #s

Economics

USA Natural Gas Storage 92B Vs 87B Est.; 50B Prior

<p>Deep-pocketed investors have adopted a bearish approach towards Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MRVL usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Marvell Tech. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 38% leaning bullish and 53% bearish. Among these notable options, 3 are puts, totaling $113,400, and 10 are calls, amounting to $563,474.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $60.0 to $70.0 for Marvell Tech over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Marvell Tech's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Marvell Tech's whale activity within a strike price range from $60.0 to $70.0 in the last 30 days. </p>
<h3>Marvell Tech Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714055462_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MRVL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$10.45</td>
<td>$10.15</td>
<td>$10.22</td>
<td>$60.00</td>
<td>$157.7K</td>
<td>225</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>MRVL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$8.8</td>
<td>$8.65</td>
<td>$8.8</td>
<td>$62.50</td>
<td>$88.0K</td>
<td>571</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>MRVL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$13.9</td>
<td>$13.8</td>
<td>$13.9</td>
<td>$62.50</td>
<td>$52.8K</td>
<td>715</td>
<td style="text-align: right;">34</td>
</tr>
<tr>
<td>MRVL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/26/24</td>
<td>$1.89</td>
<td>$1.88</td>
<td>$1.88</td>
<td>$65.00</td>
<td>$50.1K</td>
<td>1.1K</td>
<td style="text-align: right;">304</td>
</tr>
<tr>
<td>MRVL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$3.05</td>
<td>$3.0</td>
<td>$3.0</td>
<td>$60.00</td>
<td>$49.2K</td>
<td>6.6K</td>
<td style="text-align: right;">14</td>
</tr>
</tbody>
</table>
</p>
<h3>About Marvell Tech</h3>
<p>Marvell Technology is a fabless chip designer focused on wired networking, where it has the second-highest market share. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical and copper transceivers, switches, and storage controllers.</p>
<p>Having examined the options trading patterns of Marvell Tech, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Marvell Tech Standing Right Now?</h3>
<ul>
<li>With a volume of 2,081,632, the price of MRVL is up 1.03% at $65.52. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 28 days.</li>
</ul>
<h3>Expert Opinions on Marvell Tech</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $89.4.</p>
<ul>
<li>An analyst from Keybanc has decided to maintain their Overweight rating on Marvell Tech, which currently sits at a price target of $90. </li>
<li>An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $85. </li>
<li>Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on Marvell Tech with a target price of $86. </li>
<li>Reflecting concerns, an analyst from Citigroup lowers its rating to Buy with a new price target of $91.</li>
<li>In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $95. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Marvell Tech with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


MRVL

Unpacking the Latest Options Trading Trends in Marvell Tech

<p>Deep-pocketed investors have adopted a bullish approach towards Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in RIOT usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Riot Platforms. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 54% leaning bullish and 18% bearish. Among these notable options, 4 are puts, totaling $233,998, and 7 are calls, amounting to $278,056.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $10.0 to $25.0 for Riot Platforms over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Riot Platforms's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Riot Platforms's substantial trades, within a strike price spectrum from $10.0 to $25.0 over the preceding 30 days.</p>
<h3>Riot Platforms Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714055456_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$3.4</td>
<td>$3.35</td>
<td>$3.35</td>
<td>$11.00</td>
<td>$100.5K</td>
<td>286</td>
<td style="text-align: right;">300</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$1.98</td>
<td>$1.5</td>
<td>$1.7</td>
<td>$25.00</td>
<td>$72.4K</td>
<td>13.3K</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$3.2</td>
<td>$3.15</td>
<td>$3.15</td>
<td>$11.00</td>
<td>$55.7K</td>
<td>23</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>RIOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$5.5</td>
<td>$5.45</td>
<td>$5.45</td>
<td>$16.00</td>
<td>$48.5K</td>
<td>1.6K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$6.45</td>
<td>$6.1</td>
<td>$6.45</td>
<td>$10.00</td>
<td>$43.8K</td>
<td>9.6K</td>
<td style="text-align: right;">70</td>
</tr>
</tbody>
</table>
</p>
<h3>About Riot Platforms</h3>
<p>Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining; Data Center Hosting and Engineering. It generates maximum revenue from the Bitcoin Mining segment which generates revenue from the Bitcoin the company earns through its mining activities.</p>
<p>Following our analysis of the options activities associated with Riot Platforms, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of Riot Platforms</h3>
<ul>
<li>With a trading volume of 11,772,044, the price of RIOT is down by -3.45%, reaching $11.47.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 13 days from now.</li>
</ul>
<h3>What The Experts Say On Riot Platforms</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $19.2.</p>
<ul>
<li>An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $20. </li>
<li>An analyst from B. Riley Securities persists with their Buy rating on Riot Platforms, maintaining a target price of $16. </li>
<li>In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $20. </li>
<li>An analyst from ATB Capital has revised its rating downward to Outperform, adjusting the price target to $20. </li>
<li>An analyst from HC Wainwright &amp; Co. has revised its rating downward to Buy, adjusting the price target to $20. </li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Riot Platforms options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


RIOT

Decoding Riot Platforms's Options Activity: What's the Big Picture?

<p>Wells Fargo  analyst Joseph O'Dea   maintains Otis Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OTIS#NYSE">OTIS</a>) with a Equal-Weight and lowers the price target from $102 to $98.</p>


OTIS

Wells Fargo Maintains Equal-Weight on Otis Worldwide, Lowers Price Target to $98

Royal Caribbean Executive Says Regarding The Situation In The Red Sea Co Has Rerouted Some Spring Cruises; Regarding The Situation In The Red Sea Co Has Contingency Plans For A Few Other Sailings That May Be Impacted In The Fall; The Caribbean Largest Product Group, Represents 55% Of Booked Position For 2024

Federal Reserve

U.S. Treasury's Yellen Says  'China Shock' Was A Huge Loss Of Manufacturing Jobs In Parts Of U.S. That Have Not Recovered; Parts Of The U.S. Have Really 'Been Left Behind'; Free Trade Has To Be Something That Benefits People Throughout The Country; We Would Be Prepared To Use Authority To Sanction Chinese Banks If Necessary

U.S. Treasury's Yellen Says Consumer Spending In China Is 'Incredibly Low'; China Exporting Its Way To Full Employment Is Not Acceptable To The Rest Of The World; U.S. Experienced China Shock After China's Exports Surged To The U.S. Following Its Admittance To WTO

<p>Wells Fargo  analyst Joseph O'Dea   maintains Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) with a Overweight and lowers the price target from $545 to $520.</p>


Wells Fargo Maintains Overweight on Lennox Intl, Lowers Price Target to $520

S&P On Boeing Says Forecast That Cash Flow Will Be Modest In 2024 Before Improving In 2025; Timing Of Announcing Successful CEO, Chair Candidates Is Unknown, Though We Assume It Will Take Place This Year; Anticipate That Boeing Will Not Generate Sufficient Free Cash Flow In 2024 To Cover About $5B Of Debt Maturities

<p>Wells Fargo  analyst Joseph O'Dea   maintains Fortive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTV#NYSE">FTV</a>) with a Equal-Weight and lowers the price target from $92 to $84.</p>


Wells Fargo Maintains Equal-Weight on Fortive, Lowers Price Target to $84

S&P On Boeing Says Assume A Significant Increase In 2025 Deliveries, And Further Improvement Thereafter; Believe The Re-integration Of Spirit Would Likely Improve Product Quality Over The Long Term; Negative Outlook On Boeing Primarily Reflects Risk That Max Production And Delivery Increases Could Progress More Slowly Than We Expect

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>With the broader indices gaining this year, the time is ripe to check on the best <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a> on Robinhood. </p>



<p>The penny stock sector undoubtedly bears its own risks. But if played right, it can offer rewarding potential. For instance, shares of <strong>NVIDIA Corporation </strong>(NASDAQ:<span><a href="https://investorplace.com/stock-quotes/nvda-stock-quote/"><strong>NVDA</strong></a></span>) had no hope of surpassing the two-dollar barrier in the early 2000s. Yet this year, it reached its all-time high of $927.67, giving it a market cap of $2.3 trillion. Another example is <strong>Ford </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/f-stock-quote/"><strong>F</strong></a></span>), when it traded at less than $2 per share during the 2007&ndash;2008 worldwide financial crisis. Now, it&rsquo;s changing hands for $12.11.</p>



<p>We will look at three penny stocks with similar potential and double-digit upsides you can purchase on Robinhood. The first pick benefits from wider crypto trends, the second from 5G, and the last from the aging American population. Each offers potentially astounding returns for risk-taking investors.</p>



<h2>Bitfarms (BITF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/12/bitf1600-300x169.png" alt="Bitcoin and crypto mining farm. Big data center. High tech server computers at work. Bitfarms (BITF) mines crypto."><div>Source: PHOTOCREO Michal Bednarek / Shutterstock.com</div></div><p>Crypto miner <strong>Bitfarms</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/bitf-stock-quote/"><strong>BITF</strong></a>) is one of the top penny stocks on Robinhood, as Bitcoin and Ethereum zoom past <a href="https://coinmarketcap.com/community/articles/65eecb96f93110080c173404/">$71,000 and $4,000</a>, respectively. </p>



<p>The Bitcoin miner&#8288; will be one of the main beneficiaries of the <strong>Bitcoin&nbsp;</strong>(<strong><a href="https://investorplace.com/cryptocurrency/btc-usd/"><strong>BTC-USD</strong></a></strong>) bull run and the next halving. This event is why Bitcoin&rsquo;s supply is literarily constrained at 21 million. The next one will occur in April. It is commonly observed that the news about the halving often results in a substantial price increase for Bitcoin and crypto stocks. BITF shares, which have already gained 191% over the last year, are in the spotlight.</p>



<p>Bitfarms <a href="https://finance.yahoo.com/news/bitfarms-earns-357-btc-january-120000656.html">held 804 bitcoins</a> in its treasury as of the end of January. It mined 357 bitcoins in January and sold them all for $15.3 million.</p>



<p>Operational capacity remained consistent with an end-of-month operating hash rate of 6.5 exahashes per second (EH/s). Plans include boosting capacity to 21 EH/s within the year. Additionally, Bitfarms will deploy 11,600 Bitmain T21 miners in Quebec and install 1,920 MicroBT M53S+ miners in Paraguay soon. Also, it has acquired land for a <a href="https://finance.yahoo.com/news/bitfarms-earns-357-btc-january-120000656.html">new mining facility</a> in Paraguay.</p>



<p>Further, Bitfarms <a href="https://investor.bitfarms.com/news-events/press-releases/detail/232/bitfarms-purchases-additional-miners-to-reach-21-ehs-in">added 3,888 S21s</a> and 740 S21 hydro miners to its inventory. And, BITF executed options to buy 28,000 Bitmain T21 miners and 19,280 more, boosting its capacity. Moreover, Bitfarms has announced a $375 million at-the-market <a href="https://investor.bitfarms.com/news-events/press-releases/detail/231/bitfarms-announces-375-million-at-the-market-equity">equity offering program</a>, boosting shareholder returns at a critical stage&#8203;&#8203;.</p>



<p>TipRanks data indicate that investors willing to buy this stock will <a href="https://www.tipranks.com/stocks/bitf/forecast">potentially gain 86.19%</a> in upside based on a mean target of $4.45.</p>



<h2>Nokia (NOK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/08/nokia-nok-1600-300x169.jpg" alt="a backdrop featuring the Nokia logo with a mobile phone featuring the Nokia logo on its screen in the foreground"><div>Source: rafapress / Shutterstock.com</div></div><p><strong>Nokia </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/nok-stock-quote/"><strong>NOK</strong></a></span>) was once known for its mobile phone division. However, after losing the race for mobile supremacy to <strong>Apple </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/aapl-stock-quote/"><strong>AAPL</strong></a>), it pivoted to 5G technology, cloud, and network services.</p>



<p>Thanks to investments in 5G, it aims for a <a href="https://www.nokia.com/about-us/news/releases/2023/12/12/inside-information-nokia-provides-an-update-on-group-strategy-2026-comparable-operating-margin-target-and-preliminary-assumptions-for-2024/">double-digit operating margin</a> and a net sales target of around 10 billion Euro by 2026. It focuses on enterprise customers, Cloud RAN, O-RAN, and the defense sector. </p>



<p>The company wants to evolve its operating model by emphasizing SaaS and Networks as Code. In doing so, it will gain access to consistent recurring cash flow. Nokia investors could also take advantage of the Finnish multinational&rsquo;s novel merchandise introductions. In addition to <a href="https://gadgetmates.com/nokias-2024-smartphone-lineup-rumors-leaks-upcoming-releases">the XR20 and G50 phones</a>, NOK is rolling out two more products&mdash;G400 and C200 models.</p>



<p>Nokia&rsquo;s patent licensing agreements <a href="https://www.nokia.com/about-us/news/releases/2023/06/30/nokia-and-apple-sign-long-term-patent-license-agreement/">with key industry participants</a> such as Apple also demonstrate a forward-thinking approach. NOK certainly needs these initiatives to work since the stock is down 22.1% on a one-year basis. It is coming off four quarters of disappointing analyst estimates. </p>



<p>However, estimates indicate the stock <a href="https://www.tipranks.com/stocks/nok/forecast">has a 30% upside</a> potential from current rates, making it one of the best penny stocks to buy on Robinhood. </p>



<h2>Clover Health Investments (CLOV)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/clov-1600-300x169.png" alt="Clover Health logo on a phone screen in front of a computer screen showing a map where their services reach. CLOV stock."><div>Source: Wirestock Creators / Shutterstock</div></div><p><strong>Clover Health Investments&nbsp;</strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/clov-stock-quote/"><strong>CLOV</strong></a>) is one of the best penny stocks to buy on Robinhood if you want to invest in a future-oriented healthcare play. </p>



<p>The company provides Medicare Advantage insurance plans, aiming to slash costs and improve healthcare outcomes. CLOV is targeting the global Medicare Advantage market. The latter was valued at $456.6 billion in 2023 and is expected to <a href="https://www.custommarketinsights.com/report/medicare-advantage-market/#:~:text=As%20per%20the%20current%20market,to%20reach%20USD%20758.5%20Billion.">reach $758.5 billion through 2032</a>, according to an analysis from Custom Market Insights. </p>



<p>Plus, <a href="https://www.prb.org/resources/fact-sheet-aging-in-the-united-states/">the U.S. is aging rapidly</a>, with people 65 and older jumping from <a href="https://www.prb.org/resources/fact-sheet-aging-in-the-united-states/">58 million in 2022 to 82 million</a> by 2050. As a result, the total number of Medicare beneficiaries will keep growing, proving CLOV stock positive tailwinds.</p>



<p>Meanwhile, the last three quarters have been earnings-beat quarters. Clover Health Investments <a href="https://investors.cloverhealth.com/news-releases/news-release-details/clover-health-provides-business-update-and-full-year-2024">targets Adjusted EBITDA profitability</a> for the entire fiscal 2024. This will enable it to leverage its technology platform, Clover Assistant. Analysts are projecting an <a href="https://www.stockreportsplus.com/servlet/MarketView/611">82.6% upside</a> for the stock based on a mean target price of $1.44. </p>



<p>Under these circumstances, CLOV establishes itself well among the best penny stocks on Robinhood.</p>



<p><strong><em>On Penny Stocks and Low-Volume Stocks:</em></strong><em>&nbsp;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&nbsp;</em><a href="http://investorplace.com/"><em>InvestorPlace.com</em></a><em>&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em>Read More:&nbsp;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the publication date, Faizan Farooque does not hold (directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines.</em></a></p>
<div><p>Faizan Farooque is a contributing author for InvestorPlace.com and numerous other financial sites. Faizan has several years of experience in analyzing the stock market and was a former data journalist at S&amp;P Global Market Intelligence. His passion is to help the average investor make more informed decisions regarding their portfolio.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/03/3-robinhood-penny-stocks-ready-to-run/">3 Robinhood Penny Stocks Ready to Run</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Robinhood Penny Stocks Ready to Run

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>With the broader indices gaining this year, the time is ripe to check on the best <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a> on Robinhood. </p>



<p>The penny stock sector undoubtedly bears its own risks. But if played right, it can offer rewarding potential. For instance, shares of <strong>NVIDIA Corporation </strong>(NASDAQ:<span><a href="https://investorplace.com/stock-quotes/nvda-stock-quote/"><strong>NVDA</strong></a></span>) had no hope of surpassing the two-dollar barrier in the early 2000s. Yet this year, it reached its all-time high of $927.67, giving it a market cap of $2.3 trillion. Another example is <strong>Ford </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/f-stock-quote/"><strong>F</strong></a></span>), when it traded at less than $2 per share during the 2007&ndash;2008 worldwide financial crisis. Now, it&rsquo;s changing hands for $12.11.</p>



<p>We will look at three penny stocks with similar potential and double-digit upsides you can purchase on Robinhood. The first pick benefits from wider crypto trends, the second from 5G, and the last from the aging American population. Each offers potentially astounding returns for risk-taking investors.</p>



<h2>Bitfarms (BITF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/12/bitf1600-300x169.png" alt="Bitcoin and crypto mining farm. Big data center. High tech server computers at work. Bitfarms (BITF) mines crypto."><div>Source: PHOTOCREO Michal Bednarek / Shutterstock.com</div></div><p>Crypto miner <strong>Bitfarms</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/bitf-stock-quote/"><strong>BITF</strong></a>) is one of the top penny stocks on Robinhood, as Bitcoin and Ethereum zoom past <a href="https://coinmarketcap.com/community/articles/65eecb96f93110080c173404/">$71,000 and $4,000</a>, respectively. </p>



<p>The Bitcoin miner&#8288; will be one of the main beneficiaries of the <strong>Bitcoin&nbsp;</strong>(<strong><a href="https://investorplace.com/cryptocurrency/btc-usd/"><strong>BTC-USD</strong></a></strong>) bull run and the next halving. This event is why Bitcoin&rsquo;s supply is literarily constrained at 21 million. The next one will occur in April. It is commonly observed that the news about the halving often results in a substantial price increase for Bitcoin and crypto stocks. BITF shares, which have already gained 191% over the last year, are in the spotlight.</p>



<p>Bitfarms <a href="https://finance.yahoo.com/news/bitfarms-earns-357-btc-january-120000656.html">held 804 bitcoins</a> in its treasury as of the end of January. It mined 357 bitcoins in January and sold them all for $15.3 million.</p>



<p>Operational capacity remained consistent with an end-of-month operating hash rate of 6.5 exahashes per second (EH/s). Plans include boosting capacity to 21 EH/s within the year. Additionally, Bitfarms will deploy 11,600 Bitmain T21 miners in Quebec and install 1,920 MicroBT M53S+ miners in Paraguay soon. Also, it has acquired land for a <a href="https://finance.yahoo.com/news/bitfarms-earns-357-btc-january-120000656.html">new mining facility</a> in Paraguay.</p>



<p>Further, Bitfarms <a href="https://investor.bitfarms.com/news-events/press-releases/detail/232/bitfarms-purchases-additional-miners-to-reach-21-ehs-in">added 3,888 S21s</a> and 740 S21 hydro miners to its inventory. And, BITF executed options to buy 28,000 Bitmain T21 miners and 19,280 more, boosting its capacity. Moreover, Bitfarms has announced a $375 million at-the-market <a href="https://investor.bitfarms.com/news-events/press-releases/detail/231/bitfarms-announces-375-million-at-the-market-equity">equity offering program</a>, boosting shareholder returns at a critical stage&#8203;&#8203;.</p>



<p>TipRanks data indicate that investors willing to buy this stock will <a href="https://www.tipranks.com/stocks/bitf/forecast">potentially gain 86.19%</a> in upside based on a mean target of $4.45.</p>



<h2>Nokia (NOK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/08/nokia-nok-1600-300x169.jpg" alt="a backdrop featuring the Nokia logo with a mobile phone featuring the Nokia logo on its screen in the foreground"><div>Source: rafapress / Shutterstock.com</div></div><p><strong>Nokia </strong>(NYSE:<span><a href="https://investorplace.com/stock-quotes/nok-stock-quote/"><strong>NOK</strong></a></span>) was once known for its mobile phone division. However, after losing the race for mobile supremacy to <strong>Apple </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/aapl-stock-quote/"><strong>AAPL</strong></a>), it pivoted to 5G technology, cloud, and network services.</p>



<p>Thanks to investments in 5G, it aims for a <a href="https://www.nokia.com/about-us/news/releases/2023/12/12/inside-information-nokia-provides-an-update-on-group-strategy-2026-comparable-operating-margin-target-and-preliminary-assumptions-for-2024/">double-digit operating margin</a> and a net sales target of around 10 billion Euro by 2026. It focuses on enterprise customers, Cloud RAN, O-RAN, and the defense sector. </p>



<p>The company wants to evolve its operating model by emphasizing SaaS and Networks as Code. In doing so, it will gain access to consistent recurring cash flow. Nokia investors could also take advantage of the Finnish multinational&rsquo;s novel merchandise introductions. In addition to <a href="https://gadgetmates.com/nokias-2024-smartphone-lineup-rumors-leaks-upcoming-releases">the XR20 and G50 phones</a>, NOK is rolling out two more products&mdash;G400 and C200 models.</p>



<p>Nokia&rsquo;s patent licensing agreements <a href="https://www.nokia.com/about-us/news/releases/2023/06/30/nokia-and-apple-sign-long-term-patent-license-agreement/">with key industry participants</a> such as Apple also demonstrate a forward-thinking approach. NOK certainly needs these initiatives to work since the stock is down 22.1% on a one-year basis. It is coming off four quarters of disappointing analyst estimates. </p>



<p>However, estimates indicate the stock <a href="https://www.tipranks.com/stocks/nok/forecast">has a 30% upside</a> potential from current rates, making it one of the best penny stocks to buy on Robinhood. </p>



<h2>Clover Health Investments (CLOV)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/clov-1600-300x169.png" alt="Clover Health logo on a phone screen in front of a computer screen showing a map where their services reach. CLOV stock."><div>Source: Wirestock Creators / Shutterstock</div></div><p><strong>Clover Health Investments&nbsp;</strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/clov-stock-quote/"><strong>CLOV</strong></a>) is one of the best penny stocks to buy on Robinhood if you want to invest in a future-oriented healthcare play. </p>



<p>The company provides Medicare Advantage insurance plans, aiming to slash costs and improve healthcare outcomes. CLOV is targeting the global Medicare Advantage market. The latter was valued at $456.6 billion in 2023 and is expected to <a href="https://www.custommarketinsights.com/report/medicare-advantage-market/#:~:text=As%20per%20the%20current%20market,to%20reach%20USD%20758.5%20Billion.">reach $758.5 billion through 2032</a>, according to an analysis from Custom Market Insights. </p>



<p>Plus, <a href="https://www.prb.org/resources/fact-sheet-aging-in-the-united-states/">the U.S. is aging rapidly</a>, with people 65 and older jumping from <a href="https://www.prb.org/resources/fact-sheet-aging-in-the-united-states/">58 million in 2022 to 82 million</a> by 2050. As a result, the total number of Medicare beneficiaries will keep growing, proving CLOV stock positive tailwinds.</p>



<p>Meanwhile, the last three quarters have been earnings-beat quarters. Clover Health Investments <a href="https://investors.cloverhealth.com/news-releases/news-release-details/clover-health-provides-business-update-and-full-year-2024">targets Adjusted EBITDA profitability</a> for the entire fiscal 2024. This will enable it to leverage its technology platform, Clover Assistant. Analysts are projecting an <a href="https://www.stockreportsplus.com/servlet/MarketView/611">82.6% upside</a> for the stock based on a mean target price of $1.44. </p>



<p>Under these circumstances, CLOV establishes itself well among the best penny stocks on Robinhood.</p>



<p><strong><em>On Penny Stocks and Low-Volume Stocks:</em></strong><em>&nbsp;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&nbsp;</em><a href="http://investorplace.com/"><em>InvestorPlace.com</em></a><em>&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em>Read More:&nbsp;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the publication date, Faizan Farooque does not hold (directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines.</em></a></p>
<div><p>Faizan Farooque is a contributing author for InvestorPlace.com and numerous other financial sites. Faizan has several years of experience in analyzing the stock market and was a former data journalist at S&amp;P Global Market Intelligence. His passion is to help the average investor make more informed decisions regarding their portfolio.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/03/3-robinhood-penny-stocks-ready-to-run/">3 Robinhood Penny Stocks Ready to Run</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Numbers frequently take center stage in the stock market&rsquo;s maze. However, every figure has a story of strategy, ingenuity, and resiliency behind it. Here are the qualitative subtleties that characterize the success tales of three often overlooked stocks.</p>



<p>Start with the first one, a digital trailblazer with millions of fans thanks to its array of cutting-edge technologies. The company is in a very competitive state based on user-centric design and advancement, which is evident in the sheer size of its user base.</p>



<p>The second leads to the lush fields of cannabis farming colliding with the strictures of budgetary restraint. Underneath the statistics is a story of operational sharpness. Moreover, calculated investments can yield profitable operations despite the choppy conditions in the cannabis industry.</p>



<p>Finally, the third one is a key player in the story of managed healthcare reform. Beyond the data, there is a story of compassion and creativity, and each drop in the medical cost ratio reflects the organization&rsquo;s dedication to providing high-quality care while managing costs.</p>



<h2>Opera (OPRA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/12/opra-stock-1-300x169.jpg" alt="A phone displaying the Opera (OPRA) app"><div>Source: bangoland / Shutterstock.com</div></div><p><strong>Opera&rsquo;s</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/opra-stock-quote/"><strong>OPRA</strong></a></span>) profitable utilization of its platform is a major factor contributing to its potential for quick value expansion. Opera announced&nbsp;<a href="https://investor.opera.com/node/9501/pdf" target="_blank">a slight sequential rise of 313 million monthly active users</a>&nbsp;(MAUs) for Q4 2023.</p>



<p>Opera can draw and hold consumers across various products and sectors. This steady rise in the number of users demonstrates this. Considering how competitive the browser business is, the trend in MAU growth is noteworthy. Opera is on the edge of development and revenue boost potential due to its ability to retain a sizable and active user base.</p>



<p>In Q4, Opera recorded a record-breaking annualized average revenue per user&nbsp;<a href="https://seekingalpha.com/article/4674802-opera-limited-opra-q4-2023-earnings-call-transcript" target="_blank">(ARPU) of $1.44</a>, indicating a significant 22% year-over-year (YoY) growth. The rise in high-value users and the popularity of the gaming browser Opera GX are the leading causes of this spike in ARPU.&nbsp;</p>



<p>Finally, the correlation between MAU increase and ARPU growth is notable. Opera has successfully boosted its ARPU, demonstrating its ability to monetize its user base more effectively, even with a relatively small rise in total MAUs. Overall, Opera emphasizes its ability to draw in&nbsp;<a href="https://seekingalpha.com/article/4674802-opera-limited-opra-q4-2023-earnings-call-transcript" target="_blank">high-value customers</a>&nbsp;and streamline revenue methods.</p>



<h2>SNDL (SNDL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/sndl-1600-300x169.png" alt="The Sundial Growers logo is on a phone screen with a light blue background in front of the sundial logo on a white background. SNDL stock"><div>Source: Shutterstock</div></div><p>The increase in <strong>SNDL&rsquo;s</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/sndl-stock-quote/"><strong>SNDL</strong></a></span>) gross margin and cost reductions demonstrate the company&rsquo;s improving profitability, margin growth, and operational edge. Even with a minor decline in gross margin to&nbsp;<a href="https://s201.q4cdn.com/372870431/files/doc_news/SNDL-Reports-Third-Quarter-2023-Financial-and-Operational-Results-and-Achieves-Positive-Net-Cash-from-Operating-Activities-and-Free-C-G128Q.pdf" target="_blank">$48.6 million</a>&nbsp;in Q3 2023, SNDL showed notable operational gains. Hence, cost-cutting measures and margin optimization tactics propel these gains.</p>



<p>Additionally, excluding non-cash inventory impairments, the trend in gross margin growth highlights SNDL&rsquo;s efforts to increase profit and improve operational efficiency. After accounting for inventory impairments, SNDL&rsquo;s gross margin increase has surpassed 20% annually. This demonstrates the company&rsquo;s capacity to effectively manage its cost structure and boost profitability.</p>



<p>Moreover, SNDL&rsquo;s cost-cutting measures have achieved significant cost savings, including supply chain consolidation, lower SG&amp;A costs, and improved operational efficiency. By 2024, SNDL will have achieved yearly savings of&nbsp;<a href="https://s201.q4cdn.com/372870431/files/doc_earnings/2023/q3/transcript/final-sndl-inc-q3-2023-results.pdf" target="_blank">over $40 million</a>, proving its capacity to promote operational edge and optimize market value.</p>



<p>Interestingly, the relationship between gross margin improvement and cost savings underscores SNDL&rsquo;s focus on value growth and financial discipline through leveraging operational efficiencies and cost-saving measures. Lastly, with&nbsp;<a target="_blank" href="https://s201.q4cdn.com/372870431/files/doc_earnings/2023/q3/transcript/final-sndl-inc-q3-2023-results.pdf">$785 million in liquidity</a>, the debt-free balance sheet provides SNDL with considerable flexibility.&nbsp;</p>



<h2>Clover Health (CLOV)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/clov-1600-1-300x169.png" alt="Person holding cellphone with webpage of healthcare company Clover Health Investments Corp on screen with logo Focus on center of phone display. CLOV Stock."><div>Source: Wirestock Creators / Shutterstock</div></div><p>Over the past few years, <strong>Clover Health&rsquo;s</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/clov-stock-quote/"><strong>CLOV</strong></a></span>) Medical Cost Ratio (<a href="https://investorplace.com/stock-quotes/mcr-stock-quote/"><strong>MCR</strong></a>) has consistently demonstrated a declining trend. The insurance <a href="https://finance.yahoo.com/news/clover-health-investments-corp-nasdaq-131041844.html">MCR for 2021 was&nbsp;106%</a>, which means the company&rsquo;s medical expenses were more than the premiums it had received. In 2022, this ratio dropped to 91.8%, indicating improved cost control. Interestingly, Clover Health achieved a notable MCR decrease in 2023, with the insurance <a href="https://investors.cloverhealth.com/static-files/01a3ac32-054a-4723-80c7-b0721d7a3ea3">MCR falling&nbsp;to 81.2%</a>.</p>



<p>Additionally, the decrease in MCR has significant financial ramifications. A lower MCR indicates more efficiency in controlling medical costs related to premium income. A significant rise from the&nbsp;<a href="https://finance.yahoo.com/news/clover-health-investments-corp-nasdaq-131041844.html" target="_blank">$87 per member&nbsp;</a>per month (PMPM) profit in 2022 to a PMPM insurance gross profit of $245 in 2023 was achieved. The rise was derived through cost management measures. Thus, this improvement directly impacts the company&rsquo;s prospective profitability and financial performance.</p>



<p>Finally, the notable rise in MCR indicates how well Clover Health can control medical expenses. The organization improves its financial stability and profitability by decreasing the percentage of premiums allocated to medical claims. Therefore, this highlights the organization&rsquo;s capacity to generate valuation growth via cost structure optimization and member quality maintenance.</p>



<p><em>On the date of publication, Yiannis Zourmpanos did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines.</a></em></p>
<div><p>Yiannis Zourmpanos is the founder of Yiazou Capital Research, a stock-market research platform designed to elevate the due diligence process through in-depth business analysis.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/03/3-under-the-radar-stocks-to-transform-10k-into-100k-by-2028/">3 Under-the-Radar Stocks to Transform $10K into $100K by 2028</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Under-the-Radar Stocks to Transform $10K into $100K by 2028

Analyst Whit Mayo of Leerink Partners reiterated a Hold rating on Clover Health Investments (CLOV – Research Report), with a price target of $1.00....

Cautious Optimism on Clover Health's Performance with Concerns on Long-Term Profitability

Medicare expands coverage for weight loss drugs

Managed care stocks drop after Medicare rate decision

Fitch flags Medicare utilization trends ahead of managed care earnings

Clover Health appoints Peter Kuipers as CFO

The latest announcement is out from Clover Health Investments (CLOV). Clover Health Investments, Corp. has announced the appointment of Peter Kuipe...

Clover Health Appoints Peter Kuipers as New CFO

AAPL

ALHC

BITF

NONOF

NVDA

OPRA

SNDL

Press Releases

An In-Depth Analysis of Humana Inc. and the Shifting Dynamics in Medicare Advantage: Exploring the Potential for Clover Health

Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024

Management

Industry Veteran Clay Thornton Joins Clover Health as CFO of Medicare Advantage

Clover Health Reports Fourth Quarter and Full Year 2023 Financial Results; Delivers Continued Momentum in Financial Performance and Provides Full-Year 2024 Guidance

Clover Health's Remarkable Turnaround: A Deep Dive into 2023 Results and 2024 Outlook

General

Clover Health Launches New Clinical Program in Partnership with Quartet Health to Address Serious Mental Illness

Clover Health Provides Notice Associated with Previously Disclosed Settlement of Shareholder Derivative Actions

Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer